Oddrje Te Brustugun

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Hospital Universitario 12 De Octubre(Current)

Oddrje Te Brustugun is an author at Hospital Universitario 12 De Octubre specializing in cancer pharmacology, metastatic disease treatment, and chemotherapy.

Publications per year

2020–2020

Publications

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy

Edward B. Garon, Giorgio V. Scagliotti, Oliver Gautschi et al. · ESMO Open · 2020 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1